Butterfly Network has received clearance from the U.S. Food and Drug Administration (FDA) for its artificial intelligence-powered Gestational Age (GA) Tool, the first of its kind for estimating fetal age using a blind-sweep ultrasound method.
This regulatory clearance marks a significant milestone in medical imaging, introducing an AI tool designed to simplify and accelerate prenatal assessments. The GA Tool, integrated into Butterfly's handheld point-of-care ultrasound (POCUS) system, automates the process of determining how far along a pregnancy is, delivering an estimate in under two minutes. The immediate consequence is the potential to expand access to crucial obstetric imaging, particularly in emergency situations and in underserved communities where specialized sonographers are scarce.
What We Know So Far
- Butterfly Network received 510(k) clearance from the U.S. FDA for its fully automated Gestational Age (GA) Tool, according to a company announcement.
- The clearance establishes the device as the first FDA-cleared blind-sweep ultrasound AI tool specifically for estimating gestational age.
- The AI-powered tool is integrated directly into Butterfly Network's handheld, whole-body ultrasound solution, which uses a single silicon chip for imaging.
- The system provides a reliable gestational age estimate in less than two minutes through a fully automated, three-step process, as detailed by Business Wire.
- The underlying AI model was trained on a large and diverse dataset, consisting of more than 21 million ultrasound images from various patient demographics and clinical settings.
- The tool is designed to produce consistent results for pregnancies between 16 and 37 weeks.
